Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
415
-
Total 13F shares, excl. options
-
51,378,205
-
Shares change
-
-1,919,202
-
Total reported value, excl. options
-
$7,336,806,884
-
Value change
-
-$212,277,925
-
Put/Call ratio
-
141%
-
Number of buys
-
244
-
Number of sells
-
-173
-
Price
-
$142.95
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2019
493 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q1 2019.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 415 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51,378,205 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (5,068,898 shares), BlackRock Inc. (4,064,622 shares), FMR LLC (3,413,659 shares), JPMORGAN CHASE & CO (2,262,159 shares), RENAISSANCE TECHNOLOGIES LLC (1,993,101 shares), TIAA CREF INVESTMENT MANAGEMENT LLC (1,539,767 shares), STATE STREET CORP (1,470,973 shares), Boston Partners (1,305,663 shares), Bank of New York Mellon Corp (1,284,810 shares), and PUTNAM INVESTMENTS LLC (1,282,019 shares).
This table shows the top 415 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.